US4755387A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapeutic particles
Assignee: Procter and Gamble Co
•
Filing: 1985-03-21
•
Granted: 1988-07-05
•
Expires: 2005-03-21
Abstract
Abstract Therapeutic particles are disclosed which have a coating of a combination of lipids over the therapeutic agent. The lipid coating provides good stomach protection while providing good release of the therapeutic agent in the intestines.
Inventors
- 👤 Ghebre E. Tzeghai
- 👤 Paul D. Leis, Jr.
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 14:55
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5073; A61K9/5005; A61K9/5015
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
86 words
Therapeutic active particles comprising a therapeutic active having a lipid coating of a mixture of: (a) a lipid selected from the group consisting of glyceryl tristearate, glyceryl tripalmitate, monopalmityl distearyl triglyceride, dipalmityl monostearyl triglyceride and mixtures thereof; (b) a lipid selected from the group consisting of sorbitan tristearate, hexaglycerol hexapalmitate, hexaglycerol hexastearate, decaglycerol decapalmitate, decaglycerol decastearate and mixtures thereof, wherein the lipid coating comprises from about 3% to about 45% of the coated particle and the ratio of a:b is from about 1:9 to about 1:1.
Claim 2
Dependent Claim
86 words
Therapeutic active particles comprising a therapeutic active having a lipid coating of a mixture of: (a) a lipid selected from the group consisting of glyceryl tristearate, glyceryl tripalmitate, monopalmityl distearyl triglyceride, dipalmityl monostearyl triglyceride and mixtures thereof; (b) a lipid selected from the group consisting of sorbitan tristearate, hexaglycerol hexapalmitate, hexaglycerol hexastearate, decaglycerol decapalmitate, decaglycerol decastearate and mixtures thereof, wherein the lipid coating comprises from about 3% to about 45% of the coated particle and the ratio of a:b is from about 1:9 to about 1:1.
Claim 3
Dependent Claim
14 words
Thereapeutic active particles according to claim 1 wherein the therapeutic active is a nonsteroidal.
Claim 4
Dependent Claim
21 words
Therapeutic particles according to claim 2 wherein the lipid coating is from about 10% to about 30% of the coated particle.
Claim 5
Dependent Claim
21 words
Therapeutic active particles according to claim 2 wherein the coated particles are from about 0.3 to about 3 mm in diameter.
Claim 6
Dependent Claim
21 words
Therapeutic active particles according to claim 2 wherein the a lipid is glyceryl tristearate and the b lipid is sorbitan tristearate.
Claim 7
Dependent Claim
19 words
Therapeutic active particles according to claim 5 wherein the ratio of a:b is from about 1:4 to about 2:3.
Claim 8
Dependent Claim
13 words
Therapeutic active particles according to claim 6 wherein the therapeutic active is aspirin.
Claim 9
Dependent Claim
22 words
Therapeutic active particles according to claim 6 wherein the lipid coating is from about 10% to about 30% of the coated particle.
Claim 10
Dependent Claim
29 words
Therapeutic active particles according to claim 2 wherein the therapeutic active has a first coating of a polymeric enteric material and the lipid coating is over the polymeric material.
Claim 11
Dependent Claim
23 words
Therapeutic active particles according to claim 9 wherein the polymeric enteric coating is from about 3% to about 20% of the coated particle.
Claim 12
Dependent Claim
19 words
Therapeutic active particles according to claim 3 which has a polymeric enteric coating mixed in with the lipid coating.
Claim 13
Dependent Claim
26 words
A method of alleviating pain by ingesting particles of claim 1 wherein each particle contains from about 100 to about 650 milligrams of an analgesic active.
Claim 14
Dependent Claim
14 words
A method according to claim 12 wherein the particles are according to claim 2.
Claim 15
Dependent Claim
14 words
A method according to claim 12 wherein the particles are according to claim 5.
Claim 16
Dependent Claim
14 words
A method according to claim 12 wherein the particles are according to claim 7.
Claim 17
Dependent Claim
25 words
Therapeutic active granules according to claim 1 wherein the therapeutic active is selected from the group consisting of insulin, vitamins, mineral supplements and mixtures thereof.
References Cited (Backward Citations)
US2793979A
Cited
US2921883A
Cited
US3108046A
Cited
US3146167A
Cited
US3147187A
Cited
US3119742A
Cited
GB1443923A
Cited
US3965256A
Cited
US4013784A
Cited
US4182778A
Cited
US4344968A
Cited
US4483847A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-07-05 | 1992-01-04 | 1992-07-05 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-07-05 | 1996-01-04 | 1996-07-05 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-07-05 | 2000-01-04 | 2000-07-05 | $7700.00 | Window Closed / Lapsed |